Purpose To systematically investigate the longer-term clinical and health economic impacts
of genomic sequencing for rare-disease diagnoses. Methods We collected information on …

Purpose: To prospectively evaluate the diagnostic and clinical utility of singleton whole-exome
sequencing (WES) as a first-tier test in infants with suspected monogenic disease. …

Genetic diseases are leading causes of childhood mortality. Whole-genome sequencing (WGS)
and whole-exome sequencing (WES) are relatively new methods for diagnosing genetic …

Genomic sequencing is rapidly transitioning into clinical practice, and implementation into
healthcare systems has been supported by substantial government investment, totaling over …

Osteopetrosis ("marble bone disease") is a descriptive term that refers to a group of rare,
heritable disorders of the skeleton characterized by increased bone density on radiographs. …

Rare diseases are a leading cause of infant mortality and lifelong disability. To improve
outcomes, timely diagnosis and effective treatments are needed. Genomic sequencing has …

Importance Optimal use of whole-exome sequencing (WES) in the pediatric setting requires
an understanding of who should be considered for testing and when it should be performed …

Critically ill infants and children with rare diseases need equitable access to rapid and
accurate diagnosis to direct clinical management. Over 2 years, the Acute Care Genomics …

Importance Widespread adoption of rapid genomic testing in pediatric critical care requires
robust clinical and laboratory pathways that provide equitable and consistent service across …

Cockayne syndrome is an autosomal recessive multisystem disorder characterized principally
by neurological and sensory impairment, cachectic dwarfism, and photosensitivity. This …